Incomplete Suppression of HIV-1 by SAMHD1 Permits Efficient Macrophage Infection

Main Article Content

Timothy Plitnik
Mark E. Sharkey
Bijan Mahboubi
Baek Kim
Mario Stevenson

Abstract

Background: Sterile alpha motif and histidine/aspartic acid domain-containing protein (SAMHD1) is a dNTP triphosphorylase that reduces cellular dNTP levels in non-dividing cells, such as macrophages. Since dNTPs are required for reverse transcription, HIV-2 and most SIVs encode a Vpx protein that promotes proteasomal degradation of SAMHD1. It is unclear how HIV-1, which does not appear to harbor a SAMHD1 escape mechanism, is able to infect macrophages in the face of SAMHD1 restriction.

Methods: To assess whether HIV-1 had a mechanism to negate SAMHD1 activity, we compared SAMHD1 and dNTP levels in macrophages infected by HIV-1 and SIV. We examined whether macrophages infected by HIV-1 still harbored antiviral levels of SAMHD1 by assessing their susceptibility to superinfection by vpx-deleted SIV. Finally, to assess whether HIV-1 reverse transcriptase (RT) has adapted to a low dNTP environment, we evaluated SAMHD1 sensitivity of chimeric HIV-1 and SIV variants in which the RT regions were functionally exchanged.

Results: Here, we demonstrate that HIV-1 efficiently infects macrophages without modulating SAMHD1 activity or cellular dNTP levels, and that macrophages permissive to HIV-1 infection remained refractory to superinfection by vpx-deleted SIV. Furthermore, through the use of chimeric HIV/SIV, we demonstrate that the differential sensitivity of HIV-1 and SIV to SAMHD1 restriction is not dictated by RT.

Conclusions: Our study reveals fundamental differences between HIV-1 and SIV in the strategy used to evade restriction by SAMHD1 and suggests a degree of resistance of HIV-1 to the antiviral environment created by SAMHD1. Understanding how these cellular restrictions antagonize viral replication will be important for the design of novel antiviral strategies.

Keywords: HIV-1/ macrophages/ SAMHD1

Downloads

Download data is not yet available.

Article Details

Section
Articles
Author Biography

Timothy Plitnik, University of Miami

Dept. of Microbiology & Immunology

References

1. Simon V, Bloch N, Landau NR. Intrinsic host restrictions to HIV-1 and mechanisms of viral escape. Nat Immunol. 2015;16(6):546-53. PubMed PMID: 25988886. doi: 10.1038/ni.3156

2. Lahouassa H, Daddacha W, Hofmann H, Ayinde D, Logue EC, Dragin L, Bloch N, Maudet C, Bertrand M, Gramberg T, Pancino G, Priet S, Canard B, Laguette N, Benkirane M, Transy C, Landau NR, Kim B, Margottin-Goguet F. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat Immunol. 2012;13(3):223-8. PubMed PMID: 22327569. Pubmed Central PMCID: 3771401. doi: 10.1038/ni.2236

3. Franzolin E, Pontarin G, Rampazzo C, Miazzi C, Ferraro P, Palumbo E, Reichard P, Bianchi V. The deoxynucleotide triphosphohydrolase SAMHD1 is a major regulator of DNA precursor pools in mammalian cells. Proc Natl Acad Sci U S A. 2013;110(35):14272-7. PubMed PMID: 23858451. Pubmed Central PMCID: 3761606. doi: 10.1073/pnas.1312033110

4. Sattentau QJ, Stevenson M. Macrophages and HIV-1: An Unhealthy Constellation. Cell Host Microbe. 2016;19(3):304-10. PubMed PMID: 26962941. Pubmed Central PMCID: PMC5453177. doi: 10.1016/j.chom.2016.02.013

5. Amie SM, Bambara RA, Kim B. GTP is the primary activator of the anti-HIV restriction factor SAMHD1. J Biol Chem. 2013;288(35):25001-6. PubMed PMID: 23880768. Pubmed Central PMCID: 3757166. doi: 10.1074/jbc.C113.493619

6. Goldstone DC, Ennis-Adeniran V, Hedden JJ, Groom HC, Rice GI, Christodoulou E, Walker PA, Kelly G, Haire LF, Yap MW, de Carvalho LP, Stoye JP, Crow YJ, Taylor IA, Webb M. HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature. 2011;480(7377):379-82. PubMed PMID: 22056990. doi: 10.1038/nature10623

7. Kim B, Nguyen LA, Daddacha W, Hollenbaugh JA. Tight interplay among SAMHD1 protein level, cellular dNTP levels, and HIV-1 proviral DNA synthesis kinetics in human primary monocyte-derived macrophages. J Biol Chem. 2012;287(26):21570-4. PubMed PMID: 22589553. Pubmed Central PMCID: 3381122. doi: 10.1074/jbc.C112.374843

8. Gramberg T, Kahle T, Bloch N, Wittmann S, Mullers E, Daddacha W, Hofmann H, Kim B, Lindemann D, Landau NR. Restriction of diverse retroviruses by SAMHD1. Retrovirology. 2013;10:26. PubMed PMID: 23497255. Pubmed Central PMCID: 3605129. doi: 10.1186/1742-4690-10-26

9. Kaushik R, Zhu X, Stranska R, Wu Y, Stevenson M. A cellular restriction dictates the permissivity of nondividing monocytes/macrophages to lentivirus and gammaretrovirus infection. Cell Host Microbe. 2009;6(1):68-80. PubMed PMID: 19616766. Pubmed Central PMCID: 2777639. doi: 10.1016/j.chom.2009.05.022

10. Kim ET, White TE, Brandariz-Nunez A, Diaz-Griffero F, Weitzman MD. SAMHD1 restricts herpes simplex virus 1 in macrophages by limiting DNA replication. J Virol. 2013;87(23):12949-56. PubMed PMID: 24067963. Pubmed Central PMCID: 3838123. doi: 10.1128/JVI.02291-13

11. Berger A, Sommer AF, Zwarg J, Hamdorf M, Welzel K, Esly N, Panitz S, Reuter A, Ramos I, Jatiani A, Mulder LC, Fernandez-Sesma A, Rutsch F, Simon V, Konig R, Flory E. SAMHD1-deficient CD14+ cells from individuals with Aicardi-Goutieres syndrome are highly susceptible to HIV-1 infection. PLoS Pathog. 2011;7(12):e1002425. PubMed PMID: 22174685. Pubmed Central PMCID: 3234228. doi: 10.1371/journal.ppat.1002425

12. Sze A, Olagnier D, Lin R, van Grevenynghe J, Hiscott J. SAMHD1 host restriction factor: a link with innate immune sensing of retrovirus infection. J Mol Biol. 2013;425(24):4981-94. PubMed PMID: 24161438. doi: 10.1016/j.jmb.2013.10.022

13. Ryoo J, Choi J, Oh C, Kim S, Seo M, Kim SY, Seo D, Kim J, White TE, Brandariz-Nunez A, Diaz-Griffero F, Yun CH, Hollenbaugh JA, Kim B, Baek D, Ahn K. The ribonuclease activity of SAMHD1 is required for HIV-1 restriction. Nat Med. 2014;20(8):936-41. PubMed PMID: 25038827. Pubmed Central PMCID: 4318684. doi: 10.1038/nm.3626

14. Cribier A, Descours B, Valadao AL, Laguette N, Benkirane M. Phosphorylation of SAMHD1 by cyclin A2/CDK1 regulates its restriction activity toward HIV-1. Cell Rep. 2013;3(4):1036-43. PubMed PMID: 23602554. doi: 10.1016/j.celrep.2013.03.017

15. Pauls E, Jimenez E, Ruiz A, Permanyer M, Ballana E, Costa H, Nascimiento R, Parkhouse RM, Pena R, Riveiro-Munoz E, Martinez MA, Clotet B, Este JA, Bofill M. Restriction of HIV-1 replication in primary macrophages by IL-12 and IL-18 through the upregulation of SAMHD1. J Immunol. 2013;190(9):4736-41. PubMed PMID: 23526823. doi: 10.4049/jimmunol.1203226

16. Amie SM, Noble E, Kim B. Intracellular nucleotide levels and the control of retroviral infections. Virology. 2013;436(2):247-54. PubMed PMID: 23260109. Pubmed Central PMCID: 3804251. doi: 10.1016/j.virol.2012.11.010

17. Diamond TL, Roshal M, Jamburuthugoda VK, Reynolds HM, Merriam AR, Lee KY, Balakrishnan M, Bambara RA, Planelles V, Dewhurst S, Kim B. Macrophage tropism of HIV-1 depends on efficient cellular dNTP utilization by reverse transcriptase. J Biol Chem. 2004;279(49):51545-53. PubMed PMID: 15452123. Pubmed Central PMCID: 1351161. doi: 10.1074/jbc.M408573200

18. Fletcher TM, 3rd, Brichacek B, Sharova N, Newman MA, Stivahtis G, Sharp PM, Emerman M, Hahn BH, Stevenson M. Nuclear import and cell cycle arrest functions of the HIV-1 Vpr protein are encoded by two separate genes in HIV-2/SIV(SM). EMBO J. 1996;15(22):6155-65. PubMed PMID: 8947037. Pubmed Central PMCID: 452436.

19. Sharova N, Wu Y, Zhu X, Stranska R, Kaushik R, Sharkey M, Stevenson M. Primate lentiviral Vpx commandeers DDB1 to counteract a macrophage restriction. PLoS Pathog. 2008;4(5):e1000057. PubMed PMID: 18451984. Pubmed Central PMCID: 2323106. doi: 10.1371/journal.ppat.1000057

20. Liska V, Spehner D, Mehtali M, Schmitt D, Kirn A, Aubertin A-M. Localization of viral protein X in simian immunodeficiency virus macaque strain and analysis of its packaging requirements. Journal of General Virology. 1994;75: 2955-296.

21. Selig L, Pages J-C, Tanchou V, Preveral S, Berlioz-Torrent C, Liu LX, Erdtmann L, Darlix J-L, Benardous R, Benichou S. Interaction with the p6 Domain of the Gag Precursor Mediates Incorporation into Virions of Vpr and Vpx Proteins from Primate Lentiviruses. J Virol. 1999;73(1):592–600.

22. Hrecka K, Hao C, Gierszewska M, Swanson SK, Kesik-Brodacka M, Srivastava S, Florens L, Washburn MP, Skowronski J. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature. 2011;474(7353):658-61. PubMed PMID: 21720370. Pubmed Central PMCID: 3179858. doi: 10.1038/nature10195

23. Laguette N, Sobhian B, Casartelli N, Ringeard M, Chable-Bessia C, Segeral E, Yatim A, Emiliani S, Schwartz O, Benkirane M. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature. 2011;474(7353):654-7. PubMed PMID: 21613998. Pubmed Central PMCID: 3595993. doi: 10.1038/nature10117

24. McCulley A, Ratner L. HIV-2 viral protein X (Vpx) ubiquitination is dispensable for ubiquitin ligase interaction and effects on macrophage infection. Virology. 2012;427(1):67-75. PubMed PMID: 22386056. Pubmed Central PMCID: 3302174. doi: 10.1016/j.virol.2012.02.002

25. Baldauf HM, Pan X, Erikson E, Schmidt S, Daddacha W, Burggraf M, Schenkova K, Ambiel I, Wabnitz G, Gramberg T, Panitz S, Flory E, Landau NR, Sertel S, Rutsch F, Lasitschka F, Kim B, Konig R, Fackler OT, Keppler OT. SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells. Nat Med. 2012;18(11):1682-7. PubMed PMID: 22972397. Pubmed Central PMCID: 3828732. doi: doi: 10.1038/nm.2964

26. Descours B, Cribier A, Chable-Bessia C, Ayinde D, Rice G, Crow Y, Yatim A, Schwartz O, Laguette N, Benkirane M. SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4(+) T-cells. Retrovirology. 2012;9:87. PubMed PMID: 23092122. Pubmed Central PMCID: 3494655. doi: 10.1186/1742-4690-9-87

27. Hollenbaugh JA, Gee P, Baker J, Daly MB, Amie SM, Tate J, Kasai N, Kanemura Y, Kim DH, Ward BM, Koyanagi Y, Kim B. Host factor SAMHD1 restricts DNA viruses in non-dividing myeloid cells. PLoS Pathog. 2013;9(6):e1003481. PubMed PMID: 23825958. Pubmed Central PMCID: 3694861. doi: 10.1371/journal.ppat.1003481

28. Triques K, Stevenson M. Characterization of restrictions to human immunodeficiency virus type 1 infection of monocytes. J Virol. 2004;78(10):5523-7. PubMed PMID: 15113933. Pubmed Central PMCID: 400363.

29. Fregoso OI, Ahn J, Wang C, Mehrens J, Skowronski J, Emerman M. Evolutionary toggling of Vpx/Vpr specificity results in divergent recognition of the restriction factor SAMHD1. PLoS Pathog. 2013;9(7):e1003496. PubMed PMID: 23874202. Pubmed Central PMCID: 3715410. doi: 10.1371/journal.ppat.1003496

30. Planelles V, Barker E. Roles of Vpr and Vpx in modulating the virus-host cell relationship. Mol Aspects Med. 2010;31(5):398-406. PubMed PMID: 20558198. Pubmed Central PMCID: 2967654. doi: 10.1016/j.mam.2010.05.002

31. Sharp PM, Bailes E, Stevenson M, Emerman M, Hahn BH. Gene acquisition in HIV and SIV. Nature. 1996;383(6601):586-7.

32. Fujita M, Nomaguchi M, Adachi A, Otsuka M. SAMHD1-Dependent and -Independent Functions of HIV-2/SIV Vpx Protein. Front Microbiol. 2012;3:297. PubMed PMID: 22908011. Pubmed Central PMCID: 3415948. doi: 10.3389/fmicb.2012.00297

33. de Silva S, Planelles V, Wu L. Differential effects of Vpr on single-cycle and spreading HIV-1 infections in CD4+ T-cells and dendritic cells. PLoS One. 2012;7(5):e35385. PubMed PMID: 22570689. Pubmed Central PMCID: 3343049. doi: 10.1371/journal.pone.0035385

34. Schwefel D, Groom HC, Boucherit VC, Christodoulou E, Walker PA, Stoye JP, Bishop KN, Taylor IA. Structural basis of lentiviral subversion of a cellular protein degradation pathway. Nature. 2014;505(7482):234-8. PubMed PMID: 24336198. Pubmed Central PMCID: 3886899. doi: 10.1038/nature12815

35. Hartl MJ, Mayr F, Rethwilm A, Wohrl BM. Biophysical and enzymatic properties of the simian and prototype foamy virus reverse transcriptases. Retrovirology. 2010;7:5. PubMed PMID: 20113504. Pubmed Central PMCID: 2835651. doi: 10.1186/1742-4690-7-5

36. Santos-Velazquez J, Kim B. Deoxynucleoside triphosphate incorporation mechanism of foamy virus (FV) reverse transcriptase: implications for cell tropism of FV. J Virol. 2008;82(16):8235-8. PubMed PMID: 18508890. Pubmed Central PMCID: 2519572. doi: 10.1128/JVI.00088-08

37. Skasko M, Weiss KK, Reynolds HM, Jamburuthugoda V, Lee K, Kim B. Mechanistic differences in RNA-dependent DNA polymerization and fidelity between murine leukemia virus and HIV-1 reverse transcriptases. J Biol Chem. 2005;280(13):12190-200. PubMed PMID: 15644314. Pubmed Central PMCID: 1752212. doi: 10.1074/jbc.M412859200

38. Kennedy EM, Gavegnano C, Nguyen L, Slater R, Lucas A, Fromentin E, Schinazi RF, Kim B. Ribonucleoside triphosphates as substrate of human immunodeficiency virus type 1 reverse transcriptase in human macrophages. J Biol Chem. 2010;285(50):39380-91. PubMed PMID: 20924117. Pubmed Central PMCID: 2998149. doi: 10.1074/jbc.M110.178582

39. Appelberg KS, Goodenow MM. Editorial: Passive aggressive avoidance of SAMHD1 restriction by HIV-1. J Leukoc Biol. 2015;98(1):1-3. PubMed PMID: 26130765. doi: 10.1189/jlb.4CE0215-044R

40. Lenzi GM, Domaoal RA, Kim DH, Schinazi RF, Kim B. Kinetic variations between reverse transcriptases of viral protein X coding and noncoding lentiviruses. Retrovirology. 2014;11(1):111. PubMed PMID: 25524560. Pubmed Central PMCID: 4282736. doi: 10.1186/s12977-014-0111-y

41. Davies JQ, Gordon S. Isolation and culture of human macrophages. Methods Mol Biol. 2005;290:105-16. PubMed PMID: 15361658.

42. Charkerian B, Haigwood NL, Overbaugh J. Characterization of a CD4-Expressing Macaque Cell Line That Can Detect Virus after a Single Replication Cycle and Can Be Infected by Diverse Simian Immunodeficiency Virus Isolates. Virology. 1995;213:386-94.

43. Westervelt P, Gendelman HE, Ratner L. Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes. Proc Natl Acad Sci U S A. 1991;88:3097-101.

44. Ulrich A, Andersen KR, Schwartz TU. Exponential megapriming PCR (EMP) cloning--seamless DNA insertion into any target plasmid without sequence constraints. PLoS One. 2012;7(12):e53360. PubMed PMID: 23300917. Pubmed Central PMCID: 3534072. doi: 10.1371/journal.pone.0053360

45. Kestler H, Kodama T, Ringler D, Marthas M, Pedersen N, Lackner A, Regier D, Sehgal P, Daniel M, King N, Desrosiers R. Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science. 1990;248(4959):1109-12.

46. Mori K, Rosenzweig M, Desrosiers RC. Mechanisms for adaptation of simian immunodeficiency virus to replication in alveolar macrophages. J Virol. 2000;74(22):10852-9.

47. Soderberg K, Denekamp L, Nikiforow S, Sautter K, Desrosiers RC, Alexander L. A nucleotide substitution in the tRNA(Lys) primer binding site dramatically increases replication of recombinant simian immunodeficiency virus containing a human immunodeficiency virus type 1 reverse transcriptase. J Virol. 2002;76(11):5803-6. PubMed PMID: 11992009. Pubmed Central PMCID: 137045.

48. Bartz SR, Vodicka MA. Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein. Methods. 1997;12(4):337-42. PubMed PMID: 9245614. doi: 10.1006/meth.1997.0487

49. Zufferey R, Nagy D, Mandel RJ, Naldini L, Trono D. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nature Biotechnology. 1997;15:871-5.

50. Stevenson M, Haggerty S, Lamonica C, Mann AM, Meier C, Wasiak A. Cloning and characterization of human immunodeficiency virus type 1 variants diminished in the ability to induce syncytium-independent cytolysis. J Virol. 1990;64(8):3792-803.

51. Belshan M, Kimata JT, Brown C, Cheng X, McCulley A, Larsen A, Thippeshappa R, Hodara V, Giavedoni L, Hirsch V, Ratner L. Vpx is critical for SIVmne infection of pigtail macaques. Retrovirology. 2012;9:32. PubMed PMID: 22531456. Pubmed Central PMCID: 3353869. doi: 10.1186/1742-4690-9-32

52. Planelles V. Restricted access to myeloid cells explained. Viruses. 2011;3(9):1624-33. PubMed PMID: 21994799. Pubmed Central PMCID: 3187686. doi: 10.3390/v3091624

53. Berger G, Turpin J, Cordeil S, Tartour K, Nguyen XN, Mahieux R, Cimarelli A. Functional analysis of the relationship between Vpx and the restriction factor SAMHD1. J Biol Chem. 2012;287(49):41210-7. PubMed PMID: 23076149. Pubmed Central PMCID: PMC3510820. doi: 10.1074/jbc.M112.403816

54. St. Gelais C, de Silva S, Amie SM, Coleman CM, Hoy H, Hollenbaugh JA, Kim B, Wu L. SAMHD1 restricts HIV-1 infection in dendritic cells (DCs) by dNTP depletion, but its expression in DCs and primary CD4+ T-lymphocytes cannot be upregulated by interferons. Retrovirology. 2012;9(105).

55. Amie SM, Daly MB, Noble E, Schinazi RF, Bambara RA, Kim B. Anti-HIV host factor SAMHD1 regulates viral sensitivity to nucleoside reverse transcriptase inhibitors via modulation of cellular deoxyribonucleoside triphosphate (dNTP) levels. J Biol Chem. 2013;288(28):20683-91. PubMed PMID: 23744077. Pubmed Central PMCID: 3711331. doi: 10.1074/jbc.M113.472159

56. Bobadilla S, Sunseri N, Landau NR. Efficient transduction of myeloid cells by an HIV-1-derived lentiviral vector that packages the Vpx accessory protein. Gene Ther. 2013;20(5):514-20. PubMed PMID: 22895508. Pubmed Central PMCID: PMC4105013. doi: 10.1038/gt.2012.61

57. Brandariz-Nuñez A, Valle-Casuso JC, White TE, Nguyen L, Bhattacharya A, Wang Z, Demeler B, Amie S, Knowlton C, Kim B, Ivanov DN, Diaz-Griffero F. Contribution of oligomerization to the anti-HIV-1 properties of SAMHD1. Retrovirology. 2013;10(131).

58. Martinez-Picado J, Zurakowski R, Buzón MJ, Stevenson M. Episomal HIV-1 DNA and its relationship to other markers of HIV-1 persistence. Retrovirology. 2018;15(1).

59. Belshan M, Mahnke LA, Ratner L. Conserved amino acids of the human immunodeficiency virus type 2 Vpx nuclear localization signal are critical for nuclear targeting of the viral preintegration complex in non-dividing cells. Virology. 2006;346:118-26.

60. Mueller SM, Jung R, Weiler S, Lang SM. Vpx proteins of SIVmac239 and HIV-2ROD interact with the cytoskeletal protein alpha-actinin 1. J Gen Virol. 2004;85:3291-03.

61. Shaharabany M, Hizi A. The Catalytic Functions of Chimeric Reverse Transcriptases of Human Immunodeficiency Viruses Type 1 and Type 2. J Biol Chem. 1992;267(6):3674-8.

62. Ambrose Z, Boltz V, Palmer S, Coffin JM, Hughes SH, Kewalramani VN. In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques. J Virol. 2004;78(24):13553-61. PubMed PMID: 15564466. Pubmed Central PMCID: 533891. doi: 10.1128/JVI.78.24.13553-13561.2004

63. Reinhard C, Bottinelli D, Kim B, Luban J. Vpx rescue of HIV-1 from the antiviral state in mature dendritic cells is independent of the intracellular deoxynucleotide concentration. Retrovirology. 2014;11(12).

64. Bukrinsky M, Haggerty S, Dempsey M, Sharova N, Adzhubel A, Spitz L, Lewis P, Goldfarb D, Emerman M, Stevenson M. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells Nature. 1993;365(6447):666-9.

65. Zack JA, Kim SG, Vatakis DN. HIV restriction in quiescent CD4(+) T cells. Retrovirology. 2013;10:37. PubMed PMID: 23557201. Pubmed Central PMCID: PMC3626626. doi: 10.1186/1742-4690-10-37

66. Bakhanashvili M, Hizi A. Fidelity of the reverse transcriptase of human immunodeficiency virus type 2. FEBS Lett. 1992;306(2-3):151-6. PubMed PMID: 1378791.

67. Diamond TL, Kimata J, Kim B. Identification of a simian immunodeficiency virus reverse transcriptase variant with enhanced replicational fidelity in the late stage of viral infection. J Biol Chem. 2001;276(26):23624-31. PubMed PMID: 11325971. doi: 10.1074/jbc.M102496200

68. Manns A, Konig H, Baier M, Kurth R, Grosse F. Fidelity of reverse transcriptase of the simian immunodeficiency virus from African green monkey. Nucleic Acids Res. 1991;19(3):533-7. PubMed PMID: 1707165. Pubmed Central PMCID: 333644.

69. Gibbs J, Regier D, Desrosiers R. Construction and in vitro properties of HIV-1 mutants with deletions in "nonessential" genes. AIDS Res Hum Retroviruses. 1994;4:343-50.

70. Gibbs J, Regier D, Desrosiers R. Construction and in vitro properties of SIVmac mutants with deletions in "nonessential" genes. AIDS Res Hum Retroviruses. 1994;5:607-16.

71. Cribier A, Descours B, Valadão AL, Laguette N, Benkirane M. Phosphorylation of SAMHD1 by cyclin A2/CDK1 regulates its restriction activity toward HIV-1. Cell Rep. 2013;3(4):1036-43.

72. White TE, Brandariz-Nunez A, Valle-Casuso JC, Amie S, Nguyen LA, Kim B, Tuzova M, Diaz-Griffero F. The retroviral restriction ability of SAMHD1, but not its deoxynucleotide triphosphohydrolase activity, is regulated by phosphorylation. Cell Host Microbe. 2013;13(4):441-51. PubMed PMID: 23601106. Pubmed Central PMCID: 3864637. doi: 10.1016/j.chom.2013.03.005

73. Gao D, Wu J, Wu YT, Du F, Aroh C, Yan N, Sun L, Chen ZJ. Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses. Science. 2013;341(6148):903-6. PubMed PMID: 23929945. Pubmed Central PMCID: 3860819. doi: 10.1126/science.1240933

74. Jakobsen MR, Bak RO, Andersen A, Berg RK, Jensen SB, Tengchuan J, Laustsen A, Hansen K, Ostergaard L, Fitzgerald KA, Xiao TS, Mikkelsen JG, Mogensen TH, Paludan SR. IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication. Proc Natl Acad Sci U S A. 2013;110(48):E4571-80. PubMed PMID: 24154727. Pubmed Central PMCID: 3845190. doi: 10.1073/pnas.1311669110

75. Yan N, Regalado-Magdos AD, Stiggelbout B, Lee-Kirsch MA, Lieberman J. The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1. Nat Immunol. 2010;11(11):1005-13. PubMed PMID: 20871604. Pubmed Central PMCID: 2958248. doi: 10.1038/ni.1941

76. Lahaye X, Satoh T, Gentili M, Cerboni S, Conrad C, Hurbain I, El Marjou A, Lacabaratz C, Lelievre JD, Manel N. The capsids of HIV-1 and HIV-2 determine immune detection of the viral cDNA by the innate sensor cGAS in dendritic cells. Immunity. 2013;39(6):1132-42. PubMed PMID: 24269171. doi: 10.1016/j.immuni.2013.11.002